The interaction of medications used in palliative care

被引：5

作者：

Bernard, SA ^{[1
]}

机构：

[1] Univ N Carolina, Sch Med, Dept Hematol & Med Oncol, Chapel Hill, NC 27599 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2002年 / 16卷 / 03期

关键词：

D O I：

10.1016/S0889-8588(02)00014-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Medication interactions in palliative care are reviewed. An overview of drug interactions is provided with particular attention to these concepts as they apply in the palliative care setting. Newer information about the role of the CYP 450 system is reviewed. The potential for interactions with individual agents that are used in palliative care is discussed.

引用

页码：641 / +

页数：16

共 89 条

[1]

Ament PW, 1997, AM FAM PHYSICIAN, V56, P223

[2]

ARANOW RB, 1989, AM J PSYCHIAT, V146, P911

[3] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].

Barry, M ;

Gibbons, S ;

Back, D ;

Mulcahy, F .

CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209

[4] QUANTIFICATION AND MECHANISM OF THE FLUOXETINE AND TRICYCLIC ANTIDEPRESSANT INTERACTION [J].

BERGSTROM, RF ;

PEYTON, AL ;

LEMBERGER, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (03) :239-248

[5]

Bertilsson L, 1997, ACTA PSYCHIAT SCAND, V96, P14

[6] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].

BERTILSSON, L ;

HENTHORN, TK ;

SANZ, E ;

TYBRING, G ;

SAWE, J ;

VILLEN, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355

[7] PROBABLE METABOLIC INTERACTION BETWEEN METHADONE AND FLUVOXAMINE IN ADDICT PATIENTS [J].

BERTSCHY, G ;

BAUMANN, P ;

EAP, CB ;

BAETTIG, D .

THERAPEUTIC DRUG MONITORING, 1994, 16 (01) :42-45

[8] DESIPRAMINE HYDROXYLATION - VARIABILITY AND EFFECT OF ANTI-PSYCHOTIC DRUGS [J].

BOCK, JL ;

NELSON, JC ;

GRAY, S ;

JATLOW, PI .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :322-328

[9] DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].

BROLY, F ;

GAEDIGK, A ;

HEIM, M ;

EICHELBAUM, M ;

MORIKE, K ;

MEYER, UA .

DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558

[10] INHIBITION BY PAROXETINE OF DESIPRAMINE METABOLISM IN EXTENSIVE BUT NOT IN POOR METABOLIZERS OF SPARTEINE [J].

BROSEN, K ;

HANSEN, JG ;

NIELSEN, KK ;

SINDRUP, SH ;

GRAM, LF .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) :349-355

← 1 2 3 4 5 6 7 8 9 →